known
certain
felin
cell
line
crandellre
felin
kidney
cell
produc
viru
felin
endogen
retroviru
viru
exist
genom
cat
assum
contamin
viru
felin
canin
live
vaccin
manufactur
cultur
cell
felin
origin
occur
detect
infecti
viru
vitro
lacz
marker
rescu
assay
recent
establish
felin
canin
live
vaccin
approv
japan
felin
cell
line
wide
use
produc
vaccin
especi
contain
canin
parvoviru
compon
lacz
marker
rescu
assay
detect
infecti
viral
particl
realtim
reversetranscriptionpcr
detect
infecti
defect
virus
canin
live
vaccin
manufactur
cell
felin
origin
show
posit
result
env
gene
realtim
reversetranscriptionpcr
includ
vaccin
produc
felin
cell
line
neg
lacz
marker
rescu
assay
conclus
present
investig
suggest
newli
develop
method
advantag
shorter
time
requir
appli
valuabl
screen
method
detect
viral
rna
vaccin
known
certain
felin
cell
line
crandellre
felin
kidney
cell
produc
viru
felin
endogen
retroviru
viru
exist
genom
cat
assum
contamin
viru
felin
canin
live
vaccin
manufactur
cultur
cell
felin
origin
occur
detect
infecti
viru
vitro
lacz
marker
rescu
assay
recent
establish
felin
canin
live
vaccin
approv
japan
felin
cell
line
wide
use
produc
vaccin
especi
contain
canin
parvoviru
compon
lacz
marker
rescu
assay
detect
infecti
viral
particl
realtim
reversetranscriptionpcr
detect
infecti
defect
virus
canin
live
vaccin
manufactur
cell
felin
origin
show
posit
result
env
gene
realtim
reversetranscriptionpcr
includ
vaccin
produc
felin
cell
line
neg
lacz
marker
rescu
assay
conclus
present
investig
suggest
newli
develop
method
advantag
shorter
time
requir
appli
valuabl
screen
method
detect
viral
rna
vaccin
intern
associ
biolog
publish
elsevi
ltd
right
reserv
endogen
retrovirus
erv
retrovirus
integr
germ
line
cell
least
two
erv
endogen
felv
viru
present
cat
genom
viru
recombin
compris
gagpol
gene
gammaretroviru
env
gene
betaretroviru
infecti
viru
viru
known
produc
sever
felin
cell
line
crfk
cell
deriv
felin
kidney
cell
mcc
cell
deriv
felin
larg
granular
lymphoma
fer
cell
deriv
felin
fetal
fibroblast
cell
erv
gener
pathogen
origin
host
although
erv
induc
diseas
new
host
detect
infecti
viru
lacz
marker
rescu
assay
recent
establish
recent
miyazawa
et
al
found
certain
live
attenu
vaccin
cat
dog
contain
infecti
virus
mean
method
felin
canin
live
vaccin
approv
japan
produc
felin
cell
line
especi
contain
canin
parvoviru
compon
lacz
marker
rescu
assay
detect
infecti
viral
particl
realtim
reversetranscriptionpcr
detect
infecti
defect
virus
realtim
reversetranscriptionpcr
develop
give
rapid
sensit
specif
result
detect
viru
infect
detect
viru
sever
assay
develop
howev
report
realtim
reversetranscriptionpcr
addit
newli
develop
techniqu
employ
minor
groov
binder
mgb
probe
enlarg
differ
tm
valu
target
templat
nonspecif
nucleic
acid
amplif
product
obtain
high
specif
mgb
probe
also
improv
hybrid
stabil
reduc
fluoresc
background
obtain
higher
sensit
therefor
attempt
develop
realtim
reversetranscriptionpcr
method
detect
viru
canin
live
vaccin
princip
canin
live
vaccin
approv
japan
submit
present
investig
prior
expir
viral
rna
extract
vaccin
use
spin
column
qiaamp
viral
rna
mini
qiagen
ca
usa
describ
manufactur
final
volum
ml
viral
rna
extract
vaccin
rna
templat
ml
incub
ml
mixtur
consist
ml
gdna
wipeout
buffer
ml
rnase
free
water
c
min
remov
contamin
genom
dna
follow
incub
cdna
synthes
use
revers
transcriptas
rt
quantitect
revers
qiagen
ca
usa
c
min
reaction
mixtur
total
ml
consist
ml
antisens
primer
pmolml
ml
rnase
free
h
ml
rt
buffer
ml
rt
ad
dnase
treat
rna
templat
dnase
rt
inactiv
c
sequenc
data
env
gene
viru
obtain
genbank
access
specif
primer
probe
viru
use
protocol
evalu
perform
blast
search
signific
match
found
sequenc
viru
specif
primer
taqmanmgb
fluoresc
probe
design
primer
express
softwar
version
appli
biosystem
tokyo
japan
probe
label
fluoresc
report
fam
end
nonfluoresc
quencher
end
sequenc
primer
probe
follow
sens
primer
antisens
primer
probe
mgb
amplifi
fragment
bp
length
reaction
conduct
total
volum
ml
consist
ml
master
mix
taqman
gene
express
master
appli
biosystem
tokyo
japan
ml
forward
primer
pmolml
ml
revers
primer
pmolml
ml
taqman
probe
pmolml
ml
distil
water
ml
templat
realtim
pcr
perform
format
use
system
appli
biosystem
tokyo
japan
employ
follow
thermal
cycler
fig
quantit
analysi
e
amplif
profil
detect
env
gene
viru
left
right
amplif
contain
copi
cdna
respect
threshold
detect
determin
copi
ct
valu
b
e
standard
curv
creat
analysi
known
copi
target
env
gene
reaction
copi
number
target
gene
use
creat
standard
curv
standard
curv
plot
log
concentr
copi
number
ct
valu
r
set
base
taqman
standard
mode
guidelin
min
c
min
c
follow
cycl
c
min
c
assay
least
two
neg
control
distil
water
instead
cdna
templat
fluoresc
data
analyz
complet
cycl
schedul
realtim
pcr
assay
run
standard
curv
prepar
purif
gel
electrophoresi
page
refin
synthesi
cdna
contain
viru
target
sequenc
bp
serial
dilut
rang
viru
copi
cdna
use
creat
standard
curv
quantit
analysi
sampl
run
duplic
triplic
threshold
cycl
number
determin
rt
effici
test
viru
inoculum
prepar
cultur
supernat
viru
persist
infect
cell
cell
stock
viru
suspens
titer
approxim
infecti
doseml
determin
lacz
marker
rescu
assay
dilut
step
rang
medium
rna
isol
test
specif
rt
effici
lacz
marker
rescu
assay
use
detect
infecti
virus
felin
canin
live
vaccin
use
cell
human
rhabdomyosarcoma
suscept
canin
parainfluenza
viru
prevent
infect
cell
parainfluenza
viru
vaccin
neutral
anticanin
parainfluenza
viru
antibodi
neutral
antibodi
c
h
co
incub
sampl
contain
canin
parainfluenza
viru
inocul
cell
transduc
lacz
marker
gene
data
standard
sampl
use
plot
standard
curv
ct
valu
copi
number
threshold
detect
determin
copi
ct
valu
amplif
found
neg
control
amplif
result
standard
curv
shown
fig
b
copi
number
vaccin
tabl
present
realtim
reversetranscriptionpcr
method
show
posit
result
vaccin
lacz
marker
rescu
assay
tabl
equin
infecti
anemia
viru
use
specif
test
amplif
found
data
shown
rt
effici
test
standard
curv
creat
analysi
dilut
stock
viru
suspens
show
correl
coeffici
basi
relationship
viru
concentr
ct
valu
fig
b
absolut
quantif
viral
rna
level
reversetranscript
effici
consid
extrem
signific
present
data
fig
show
correl
coeffici
ct
valu
initi
viru
concentr
indic
optimum
condit
newli
establish
realtim
reversetranscriptionpcr
realtim
reversetranscriptionpcr
lacz
marker
rescu
assay
detect
viral
rna
infecti
retrovirus
respect
word
former
detect
defect
infecti
viral
particl
latter
detect
infecti
viru
particl
case
lacz
marker
rescu
assay
method
establish
detect
infecti
viru
vaccin
method
time
consum
requir
day
sampl
inocul
cell
transduc
lacz
marker
gene
realtim
reversetranscriptionpcr
method
advantag
lacz
marker
rescu
assay
sever
way
eas
use
speed
applic
gener
laboratori
particularli
multispecimen
materi
process
perform
pcr
method
also
gener
detect
defect
viral
particl
therebi
provid
use
aid
screen
test
furthermor
threshold
copi
could
detect
canin
live
vaccin
manufactur
cell
felin
origin
show
posit
result
env
gene
realtim
reversetranscriptionpcr
includ
vaccin
produc
felin
cell
line
neg
lacz
marker
rescu
assay
canin
live
vaccin
manufactur
cultur
cell
mink
origin
posit
assay
result
show
mink
cell
canin
parvoviru
seed
stock
may
contamin
viru
sinc
mink
lung
cell
suscept
varieti
retrovirus
extens
use
isol
propag
endogen
primat
retrovirus
might
caus
enorm
increas
viru
contamin
vaccin
canin
live
vaccin
manufactur
cultur
cell
neg
realtim
reversetranscriptionpcr
method
except
cat
origin
howev
possibl
contamin
low
copi
number
viru
detect
result
realtim
reversetranscriptionpcr
demonstr
contamin
viru
fig
specif
rt
effici
lacz
marker
rescu
assay
method
viru
concentr
rang
could
detect
e
stock
viru
liquid
dilut
serial
dilut
rang
medium
b
e
standard
curv
creat
analysi
dilut
stock
viru
liquid
ct
valu
obtain
viru
concentr
r
canin
live
vaccin
predominantli
origin
vaccin
manufactur
cell
felin
origin
first
report
demonstr
presenc
viru
canin
live
vaccin
use
realtim
reversetranscriptionpcr
method
taqman
mgb
probe
viru
product
infect
cell
cat
dog
may
transmit
nonfelin
speci
vivo
xenotrop
featur
viru
demonstr
tabl
felin
cell
line
produc
viral
particl
contain
viral
rna
presum
felin
cell
line
use
produc
vaccin
produc
viru
irrespect
infect
present
complet
risk
assess
would
imposs
minimum
infecti
dose
pathogen
knowledg
still
unclear
conclus
present
investig
suggest
newli
develop
method
advantag
shorter
time
requir
use
screen
method
detect
viral
rna
vaccin
howev
assay
detect
infecti
viral
particl
still
need
although
risk
caus
contamin
viru
unknown
present
suppos
infecti
virus
elimin
live
vaccin
least
appropri
regulatori
tool
present
realtim
reversetranscriptionpcr
method
greatli
improv
qualiti
control
canin
live
vaccin
minim
occurr
unexpect
risk
advers
event
vaccin
dog
